Overview
Mucosal lentiginous melanoma is a rare variant of melanoma that arises from mucosal surfaces, including the sinonasal, anogenital, and conjunctival regions, often with distinct genetic profiles and poorer prognoses compared to cutaneous melanomas 12.Diagnosis
Biopsy confirmation is essential for diagnosis 3.
Genetic testing for mutations such as BRAF, NRAS, and KIT can provide prognostic information 12.
Presence of brisk tumor-infiltrating lymphocytes may correlate with better outcomes 1.
Pathologic assessment should consider unique factors like margin evaluation specific to mucosal sites 5.Management
First-line treatment: Immune checkpoint inhibitors (e.g., anti-PD-1/PD-L1) are increasingly used, with reported 5-year overall survival rates around 42.6% 1.
Adjuvant therapy: Consideration of immunotherapy in adjuvant settings based on genetic profiles and clinical stage 1.
Surgical intervention: Primary or adjuvant surgery may be indicated depending on extent and location 3.
Radiotherapy: Used in cases where surgery is not feasible or as an alternative to immunotherapy 3.Special Populations
Elderly patients: Limited specific guidance; management often tailored to comorbidities and performance status 3.
Comorbidities: Impact on treatment selection and tolerance, particularly for immunotherapy 1.Key Recommendations
Utilize genetic testing for BRAF, NRAS, and KIT mutations to guide treatment decisions (Evidence: Moderate 12).
Consider immune checkpoint inhibitors as a first-line or adjuvant treatment option, especially in patients with brisk tumor-infiltrating lymphocytes (Evidence: Moderate 1).
Implement standardized pathologic reporting guidelines for mucosal melanomas to ensure consistent diagnosis and prognosis assessment (Evidence: Expert opinion 5).
Tailor management strategies considering patient-specific factors such as age and comorbidities (Evidence: Expert opinion 3).References
1 Tang A, Taori S, Dang S, Gardner PA, Zenonos GA, Davar D et al.. Immunotherapy in the Management of Sinonasal Mucosal Melanoma: A Systematic Review. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2024. link
2 Beaudoux O, Oudart JB, Riffaud L, Visseaux L, Marchal A, Lebre AS et al.. Mutational Characteristics of Primary Mucosal Melanoma: A Systematic Review. Molecular diagnosis & therapy 2022. link
3 Li L, London NR, Chen X. Malignant Mucosal Melanoma of the Eustachian Tube With Extension Into the Ipsilateral External Ear Canal: A Case Report and Review of the Literature. Ear, nose, & throat journal 2021. link
4 Smith HG, Bagwan I, Board RE, Capper S, Coupland SE, Glen J et al.. Ano-uro-genital mucosal melanoma UK national guidelines. European journal of cancer (Oxford, England : 1990) 2020. link
5 Williams MD, Franchi A, Helliwell T, Müller S, Thompson LDR. Data Set for the Reporting of Mucosal Melanomas of the Head and Neck: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting. Archives of pathology & laboratory medicine 2019. link
6 Rosenblum GA. Cryotherapy of lentiginous mosaicism. Cutis 1985. link